Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Off-Label Dissemination Keeps FDA Stuck Between Prosecutors And Firms

Executive Summary

As industry weighs the potential impact of FDA's guidance on good reprint practices, stakeholders are suggesting alternate policy approaches that could give companies sufficient clarity on how to conduct off-label dissemination

You may also be interested in...



False Claims Act Suits May Become Harder After Supreme Court Ruling

A U.S. Supreme Court ruling restricts when whistleblowers can sue someone for fraud against the government. But the opinion is limited to certain situations and may not affect suits brought against drug companies

False Claims Act Suits May Become Harder After Supreme Court Ruling

A U.S. Supreme Court ruling restricts when whistleblowers can sue someone for fraud against the government. But the opinion is limited to certain situations and may not affect suits brought against drug companies

FDA’s Off-Label Reprint Guidance Is Unlikely To Clarify Anything Very Soon

Companies hoping that the end of the comment period for FDA's draft guidance on "good reprint practices" will swiftly produce a final roadmap should probably not hold their breath

Related Content

UsernamePublicRestriction

Register

GB140150

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel